Cargando…

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation

Since tau PET tracers were introduced, investigators have quantified them using a wide variety of automated methods. As longitudinal cohort studies acquire second and third time points of serial within-person tau PET data, determining the best pipeline to measure change has become crucial. We compar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarz, Christopher G., Therneau, Terry M., Weigand, Stephen D., Gunter, Jeffrey L., Lowe, Val J., Przybelski, Scott A., Senjem, Matthew L., Botha, Hugo, Vemuri, Prashanthi, Kantarci, Kejal, Boeve, Bradley F., Whitwell, Jennifer L., Josephs, Keith A., Petersen, Ronald C., Knopman, David S., Jack, Clifford R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407434/ https://www.ncbi.nlm.nih.gov/pubmed/34118395 http://dx.doi.org/10.1016/j.neuroimage.2021.118259

Ejemplares similares

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
por: Schwarz, Christopher G., et al.
Publicado: (2018)

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
por: Schwarz, Christopher G., et al.
Publicado: (2019)

MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
por: Josephs, Keith A., et al.
Publicado: (2020)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Contributions of imprecision in PET‐MRI rigid registration to imprecision in amyloid PET SUVR measurements
por: Schwarz, Christopher G., et al.
Publicado: (2017)

Predicting future rates of tau accumulation on PET
por: Jack, Clifford R, et al.
Publicado: (2020)

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
por: Whitwell, Jennifer L., et al.
Publicado: (2019)

Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers
por: Cogswell, Petrice M., et al.
Publicado: (2020)

Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
por: Schwarz, Christopher G., et al.
Publicado: (2023)

Improved DTI registration allows voxel-based analysis that outperforms Tract-Based Spatial Statistics
por: Schwarz, Christopher G., et al.
Publicado: (2014)

Face recognition from research brain PET: An unexpected PET problem
por: Schwarz, Christopher G., et al.
Publicado: (2022)

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
por: Jack, Clifford R, et al.
Publicado: (2019)

Non-Stationarity in the “Resting Brain’s” Modular Architecture
por: Jones, David T., et al.
Publicado: (2012)

Investigation of white matter PiB uptake as a marker of white matter integrity
por: Zeydan, Burcu, et al.
Publicado: (2019)

Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET
por: Nedelska, Zuzana, et al.
Publicado: (2018)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
por: Zeydan, Burcu, et al.
Publicado: (2020)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model
por: Therneau, Terry M., et al.
Publicado: (2021)

(18)F‐AV‐1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy
por: Nedelska, Zuzana, et al.
Publicado: (2019)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
por: Vemuri, Prashanthi, et al.
Publicado: (2018)

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
por: Vemuri, Prashanthi, et al.
Publicado: (2015)

Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia
por: Nedelska, Zuzana, et al.
Publicado: (2019)

Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
por: Jack, Clifford R., et al.
Publicado: (2022)

Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?()
por: Whitwell, Jennifer L., et al.
Publicado: (2013)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2022)

A face-off of MRI research sequences by their need for de-facing
por: Schwarz, Christopher G., et al.
Publicado: (2023)

Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study
por: Jack, Clifford R., et al.
Publicado: (2017)

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity
por: Schwarz, Christopher G., et al.
Publicado: (2016)

White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023)

Rates of transition between amyloid and neurodegeneration biomarker states and to dementia among non-demented individuals: a population-based cohort study
por: Jack, Clifford R., et al.
Publicado: (2015)

Cross–scanner harmonization methods for structural MRI may need further work: A comparison study
por: Gebre, Robel K., et al.
Publicado: (2023)

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers
por: Cogswell, Petrice M., et al.
Publicado: (2023)

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
por: Jack, Clifford R., et al.
Publicado: (2014)

Elevated medial temporal lobe and pervasive brain tau-PET signal in normal participants
por: Lowe, Val J., et al.
Publicado: (2018)

Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
por: Jack, Clifford R., et al.
Publicado: (2019)

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
por: Jack, Clifford R., et al.
Publicado: (2015)

(18)F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies
por: Graff-Radford, Jonathan, et al.
Publicado: (2020)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j7u1t4pj8qj8ei9i4llji00sj1